Effects of Toceranib Phosphate on the Hypothalamic-Pituitary-Thyroid Axis in Tumor-Bearing Dogs.

Kelly R HumeV L RizzoJ R CawleyC E Balkman

Published in: Journal of veterinary internal medicine (2017)

Toceranib phosphate can disrupt the hypothalamic-pituitary-thyroid axis in dogs. Periodic evaluation of TT4, FT4, TT3, and TSH should be carried out in dogs receiving long-term treatment with this medication.

Keyphrases

healthcare
growth hormone
adverse drug
combination therapy
replacement therapy